Batsis, Prado, and colleagues, writing in Annals of Internal Medicine , applied prespecified benchmarks for expected muscle-related losses about 25% of total weight loss for FFM or lean soft tissue measured by BIA or DXA, and about 15% for skeletal muscle measured by CT or MRI
International journal of molecular sciences , 24 (15), 12152
Adverse events are reported as a percentage, but these are also participants who are recording anything that they feel
Understanding your genetic and biomarker context can support a more informed, collaborative conversation with your healthcare provider about whether compounded semaglutide is appropriate for you, what monitoring schedule makes sense, and how to adjust thyroid replacement as your metabolism changes